LOS ANGELES, Oct. 15, 2024 – Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have the opportunity to lead the securities fraud class action lawsuit against Metagenomi, Inc. (“Metagenomi” or the “Company”) MGX.
Opportunity to Lead Lawsuit
Class Period: February 2024 IPO
Lead Plaintiff Deadline: November 25, 2024
If you aspire to spearhead the Metagenomi lawsuit, do submit your contact information at www.glancylaw.com/cases/Metagenomi-Inc/. Reach out to Charles H. Linehan of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com for more insights into your rights.
Allegations
The complaint contends that during the Class Period, the Defendants omitted to inform investors that Metagenomi’s partnership with Moderna would cease promptly rather than endure in the future. Consequently, the Defendants’ optimistic statements about the Company’s business, operations, and prospects were significantly misleading and/or lacked a valid basis at all pertinent times.
Stay updated on developments via LinkedIn, Twitter, or Facebook. If you’re part of the class action, you’re not mandated to take any action presently. You can engage legal counsel of your choosing or observe without participation. Reach out to Charles Linehan, Esquire, of GPM, at 310-201-9150, Toll-Free at 888-773-9224, shareholders@glancylaw.com, or visit www.glancylaw.com for additional information.
Mustering Attorney Advertising regulations may apply to this press release in certain jurisdictions as per the prevailing law and ethical norms.
Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com – www.glancylaw.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/mgx-investors-have-opportunity-to-lead-metagenomi-inc-securities-fraud-lawsuit-302271173.html
SOURCE Glancy Prongay & Murray LLP
Market News and Data brought to you by Benzinga APIs